Joana Erdmann

Ms. Joana Erdmann

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2025 in Helvetica Chimica Acta
Verified
Journal Article
Open access
JEJoana Erdmann
Joana Erdmann
RKRichard Kuehl
Richard Kuehl
MMMario Morgenstern
Mario Morgenstern
DBDirk Bumann
Dirk Bumann
MCMartin Clauss
Martin Clauss
KRKatharina M. Rentsch
Katharina M. Rentsch
Amoxicillin is a frequently used beta‐lactam antibiotic and at the same time a fragile analyte. Aim of this work was to investigate the sensitive properties of amoxicillin in biological samples and validate a quantification method for amoxicillin in soft tissue samples. Simple protein precipitation and 2D‐High performance liquid chromatography coupled to tandem mass spectrometry was used for sample preparation and analysis. The formation of a covalent amoxicillin methanol‐adduct could be observed in varying extents depending on matrix and sample preparation method. In‐Source Products (ISPs) were investigated in plasma, soft tissue, and water and no differences could be observed. We successfully validated a method for amoxicillin determination in tissue samples using the sum of 2 ISPs of amoxicillin for quantification. 37 study samples of different deep‐seated infections could be analyzed. Measured amoxicillin concentrations ranged from below 0.5 mg/kg up to 87 mg/kg. Concentrations in abscesses were lower than in other infections.

25 September 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
JEJoana Erdmann
Joana Erdmann
LVLinh Anna Trúc Vu
Linh Anna Trúc Vu
HDHalbeisen Delia
Halbeisen Delia
KRKatharina M. Rentsch
Katharina M. Rentsch
Background/Objectives: Parenteral antibiotic therapy is indispensable in the treatment of several infections. The parenteral administration often leads to the need for prolonged hospitalization. Therefore, interest in outpatient parenteral antimicrobial therapy (OPAT) is growing. OPAT is typically administered in elastomeric devices, which release an infusion solution over a 24 h period and are meanwhile worn close to the body. This work aimed to evaluate the stability of the reserve antibiotics ceftazidime-avibactam and ceftolozane-tazobactam for OPAT use. Methods: Elastomeric pumps were prepared in triplicate at the dosages 3.75 and 7.5 g of ceftazidime-avibactam and 2.25, 4.5, and 9.0 g of ceftolozane-tazobactam in 240 mL 0.9% saline each. The pumps were first stored at 2–8 °C for 7 days and subsequently incubated for 48 h at 25 °C. To determine actual concentrations of ceftazidime, avibactam, ceftolozane, tazobactam, and pyridine, samples were taken at nine different time points during storage and incubation. High-performance liquid chromatography coupled to tandem mass spectrometry was used for quantification. Results: Although concentrations of ceftazidime and avibactam stayed above 90% during a 24 h incubation period at 25 °C, the pyridine limit of the European Pharmacopeia was already exceeded in the ceftazidime-avibactam pumps after the storage time at 2–8 °C. In the ceftolozane-tazobactam pumps, the ceftolozane concentration was stable for 24 h incubation, but tazobactam concentrations decreased below 90% within 12 h in the two higher dosages. Conclusions: Accordingly, stability cannot be guaranteed for both tested preparations and their use for OPAT should be thoroughly considered.

24 November 2023 in Orthopaedic Proceedings
Verified
Journal Article
Closed access
JEJoana Erdmann
Joana Erdmann
MCMartin Clauss
Martin Clauss
NKNina Khanna
Nina Khanna
RKRichard Kühl
Richard Kühl
FLFanny Linder
Fanny Linder
KRKatharina Rentsch
Katharina Rentsch
AMOXICILLIN IN DEEP-SEATED SAMPLES: QUANTIFICATION OF A DELICATE COMPOUND

3 June 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
BMBenedict Morin
Benedict Morin
VTVishwachi Tripathi
Vishwachi Tripathi
AWAnne-Kathrin Woischnig
Anne-Kathrin Woischnig
JEJoana Erdmann
Joana Erdmann
AIAya Iizuka
Aya Iizuka
Nina KhannaNina Khanna
Nina Khanna
Staphylococcus aureus is a leading cause of musculoskeletal infection with frequent recurrence despite surgery and antibiotic therapy. Its persistence in human tissues under antibiotic pressure remains unclear. We performed longitudinal in situ analyses of matched tissue samples before and during therapy from patients undergoing repeated surgery using advanced imaging and tissue-based metagenomics. S. aureus remained detectable in all samples - including culture-negative specimens - and whole-genome sequencing confirmed persistence of the infecting strain. Antibiotic initiation reduced bacterial burden by 1.05log10 bacteria/mm^3 but residual loads stabilized thereafter. Quantitative imaging identified a culture detection threshold (~10^3bacteria/mm^3), indicating that culture negativity reflects diagnostic sensitivity limits rather than true bacterial clearance. Persistence under antibiotic therapy was associated with high baseline burden and intracellular sequestration, whereas long-term persistence was characterized by predominantly extracellular bacteria capable of driving relapse. These findings reveal sustained tissue persistence despite apparent microbiological clearance and guide precision strategies to target resilient bacterial reservoirs.